Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Patience our time will come.
Synonyms
1. composure, stability, self-possession; submissiveness, sufferance. Patience, endurance, fortitude, stoicism imply qualities of calmness, stability, and persistent courage in trying circumstances. Patience may denote calm, self-possessed, and unrepining bearing of pain, misfortune, annoyance, or delay; or painstaking and untiring industry or (less often) application in the doing of somehing: to bear afflictions with patience. Endurance denotes the ability to bear exertion, hardship, or suffering (without implication of moral qualities required or shown): Running in a marathon requires great endurance. Fortitude implies not only patience but courage and strength of character in the midst of pain, affliction, or hardship: to show fortitude in adversity. Stoicism is calm fortitude, with such repression of emotion as to seem almost like indifference to pleasure or pain: The American Indians were noted for stoicism under torture. 3. indefatigability, persistence, assiduity.
Steeler and Lion are true trades. Great to share this road with you all of you.
23 mill locked at 1.00
EVDR
The revenue should be great. I have had this stock since January 2011. Its about time.
#15 NOW :)
NOW AT #20
Evader went from #31 to #21 on the breakout board in the past hour. This will be a nice week Don't sell to soon. You might miss the big wave.
EVADER #21 ON THE BREAKOUT BOARD. SHOULD BE IN THE TOP 10 BY TOMORROW.
Thu Jun 07 13:38:15 2012 Buy 500000 EVDR Executed @ $0.001
Account: xxxx-xxxx Your Day buy order for 500000 EVDR at a limit price of $0.001 was executed at $0.001. See order # 146 for details.
(c) 2010 E*TRADE Securities LLC, Member FINRA/SIPC. All rights reserved. The information contained in this Smart Alert does not constitute a recommendation by E*TRADE Securities, and is subject to the Smart Alerts Terms and Conditions and the E*TRADE Securities Customer Agreement. We cannot respond to e-mails sent to this mailbox. If you have questions, please contact us through the Online Service Center.
Thu Jun 07 12:30:41 2012 Buy 400000 EVDR Executed @ $0.001
Account: xxxx-0617 Your Day buy order for 400000 EVDR at a limit price of $0.001 was executed at $0.001. See order # 144 for details.
(c) 2010 E*TRADE Securities LLC, Member FINRA/SIPC. All rights reserved. The information contained in this Smart Alert does not constitute a recommendation by E*TRADE Securities, and is subject to the Smart Alerts Terms and Conditions and the E*TRADE Securities Customer Agreement. We cannot respond to e-mails sent to this mailbox. If you have questions, please contact us through the Online Service Center.
Got 1,100,000 @ 0.0010. WEEEEEEEEEEEEEeeeeeeeeeeeeeeeeeeeeeee.
Thank you for the invite Psionic Trader.
4 weeks till the 1st Quarter of 2012 comes out. If they can beat the first quarter of 2011. This stock will be well on its way up. It takes money to make money. They are investing into the growth of the company. There are stocks that have spent more money, and have a lot less revenue and there pps is higher. I am not worried about this stock. IMO
The filling says they have up to 15 days after April 14th to file.
Here are the last 6 years revenue reports.
2005 7,403
2006 37,363
2007 44,847
2008 53,235
2009 14,264
2010 133,869
2011 459,451
Past 6 years 290,981.
2011 is up 361,582 from 2010.
Net loss is down 383,352 from 2010
This year will be MDFI year.
Net loss is down $383,352. From 2010.
Revenues are up 361,582. From 2010.
The numbers show large growth.
I live 15min from Medefiles offices. I have been their. They have expanded since the beginning of 2011.
Anyone can see this is just the beginning.
MedePro
Introduced in 2012, MedePro is a medical record retrieval and document management solution created specifically by MedeFile for legal and insurance professionals.
For Legal Professionals
Medical record retrieval and document management play critical roles in helping plaintiff or defense counsels build, support and win their cases, be them mass tort, malpractice, personal injury, product liability, workers’ compensation or other types of health- or medical-related litigation. However, the sheer cost, manpower and time required to request, retrieve and manage what is typically hundreds, if not thousands, of records can be overwhelming. Upon engagement, MedeFile’s highly competent MedePRO customer service agents and our proprietary electronic retrieval system go to work contacting case-related healthcare providers nationwide to collect copies of all actual medical records and files – including actual notes, EKGs, X-rays, MRIs, labs, et al. Then, using a secure, double encrypted process, MedeFile consolidates, digitizes, indexes, paginates, Bates stamps, stores and protects the records in the MedeVault, MedeFile’s proprietary, highly secure, redundant electronic depository which can only be accessed by authorized individuals.
Retrieved medical records can be searched and viewed online through MedeFile’s secure online portal from anywhere on Earth using an Internet-enabled desktop computer or mobile computing device. In addition, individual and/or collective documents can also be downloaded, shared with co-counsels (essential for large mass tort cases), and copied to a MedeDrive, a proprietary USB thumb drive ideal for portability and convenient and economical long term storage.
The MedePRO solution may also be seamlessly integrated into a law firm’s case management system to facilitate real-time, one-click status checks of requested records, helping to expedite case discovery and complex trial preparation.
For Insurance Professionals
In collaboration with medical insurance providers and with proper authorization, MedePRO enables the expeditious, secure retrieval and management of all actual medical records and files from a patient’s current and former care providers. Records received are then digitized, indexed, coded and stored in the MedeVault, from which case managers can access, view, share and download a patient’s comprehensive, longitudinal personal health record from any web-enabled device. Further, MedePRO’s online record order tracking system allows case managers to view real-time status reports on a 24/7 basis. Insurance professionals can also tap the power and convenience of MedePRO for the purpose of analyzing medical claims or investigating and adjudicating medical identity theft and fraud.
Here are the last 6 years revenue reports.
2005 7,403
2006 37,363
2007 44,847
2008 53,235
2009 14,264
2010 133,869
2011 ?
Past 6 years 290,981.
Medefile has beaten the combined last 6 years of revenue in the first 3 quarters of 2011 @ 403,644.
This year will be MDFI year.
"If a filing due date falls on a weekend or SEC holiday, the filing is due on the following business day."
So Monday 4/16 would be the last acceptable day for a on time 10-k filing.
They have 15 days from March 30th to report. That gives them till April 14th.
Definition of 'SEC Form NT 10-K'
A filing with the Securities and Exchange Commission (SEC) that a company must submit when it is unable to file its 10-K, or similar form, on time.
After submission of the SEC Form NT 10-K, the company must then file its 10-K within 15 days.
The 10-K is an annual report that provides a comprehensive overview of the company's business activities. This report must be filed within 90 days of the end of the company's fiscal year.
Does anyone know when this report will be out?
Does anyone know when this report will be out?
MDFI MEDEFILE STARTING ITS RUN :)
MedeFile Announces Global Expansion Led by Joint Venture in Spain
8:30 AM ET 3/27/12 | Marketwire
Next Earnings Announcement 04/02/2012
VALUATION
Market Cap (M USD) 3.52
Volume 12,375,432
Price/Book (mrq) 8.5783
Price/Sales (ttm) 5.9689
PEG Ratio (3 year expected) -
Estimated PEG Ratio -
Enterprise Value (M USD) 3.04
EBITDA -1.23
Enterprise Value/EBITDA (ttm) -
Enterprise Value/Revenue (ttm) 6.24
EARNINGS
Earnings Per Share (ttm) 0.0000
Quarter Estimated EPS (mrq) -
Year Estimated EPS -
P/E Ratio (ttm) -
Estimated P/E -
Relative P/E vs. SPX -
Next Earnings Announcement 04/02/2012
0.055 for the ask in the morning. :)
Form 8-K for NEOMEDIA TECHNOLOGIES INC
27-Mar-2012
Entry into a Material Definitive Agreement, Financial Statements and Ex
Item 1.01. Entry Into a Material Definitive Agreement
Agreement and Debenture Closing, March 26, 2012
On March 26, 2012, NeoMedia Technologies, Inc., a Delaware corporation (the " Company " ), entered into an Agreement (the " Agreement "), a copy of which is attached hereto as Exhibit 10.1 and incorporated by reference herein, to issue and sell a secured convertible debenture to YA Global Investments, L.P. (the " Buyer ") in the principal amount of $450,000 (the " Debenture "), a copy of which is attached hereto as Exhibit 10.2 and incorporated by reference herein. The closing of the transaction was held on March 26, 2012. In addition to the Debenture, the Company also issued a warrant to the Buyer to purchase 1,000,000 shares of the Company's common stock, par value $0.001 per share (the " Common Stock "), for an exercise price of $0.15 per share (the "Warrant "), a copy of which is incorporated by reference herein and attached hereto as Exhibit 10.3 .
The Debenture shall mature on July 29, 2012 ( the " Maturity Date ") and shall accrue interest at a rate equal to fourteen percent (14%) per annum and such interest shall be paid on the Maturity Date (or sooner as provided in the Debenture) in cash or, provided that certain Equity Conditions are satisfied (as such term is defined in the Debenture ), in shares of Common Stock at the applicable Conversion Price (as defined in the Debenture ). At any time, the Buyer shall be entitled to convert any portion of the outstanding and unpaid principal and accrued interest thereon into fully paid and non-assessable shares of Common Stock at a price equal to the lesser of $0.10 and ninety-five percent (95%) of the lowest volume weighted average price of the Common Stock during the sixty (60) trading days immediately preceding each conversion date.
The Debenture is secured by certain pledges made with respect to the assets of the Company and its subsidiaries as set forth in the Seventeenth Ratification Agreement dated March 26, 2012 (the "Ratification Agreement"), and that certain Security Agreement (the "Security Agreement") and Patent Security Agreement (the "Patent Security Agreement") both dated July 29, 2008, by and among the Company, each of the Company's subsidiaries made a party thereto, and the Buyer. Copies of the Security Agreement and the Patent Security Agreement are incorporated by reference herein and attached by reference hereto as Exhibits 10.4 and 10.5, respectively. The Ratification Agreement is incorporated by reference herein and attached as Exhibit 10.6 hereto.
In connection with the Agreement, the Company also entered into those certain Irrevocable Transfer Agent Instructions (the "ITAI") with the Buyer, an escrow agent and WorldWide Stock Transfer, LLC, the Company's transfer agent, a copy of which is incorporated herein by reference and attached as Exhibit 10.7 hereto.
The Company shall not affect any conversion, and the Buyer shall not have the right to convert any portion of the Debenture to the extent that after giving effect to such conversion, the Buyer (together with the Buyer's affiliates) would beneficially own in excess of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such conversion, except for not less than sixty-five (65) days prior written notice from the Buyer.
The Company shall have the right to redeem a portion or all amounts outstanding (subject to certain conditions) in the Debenture via Optional Redemption (as defined in the Debenture) by paying the amount equal to the principal amount being redeemed plus a redemption premium equal to ten percent (10%) of the principal amount being redeemed, and accrued interest.
The foregoing descriptions of the Agreement, Debenture, Warrant, Security Agreement, Patent Security Agreement, Ratification Agreement and ITAI do not purport to be complete and are qualified in their entirety by reference to such documents, which are attached or incorporated by reference as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5, 10.6, and 10.7, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(a) Not applicable.
(b) Not applicable.
(c) Not applicable.
(d) Exhibits .
EXHIBIT DESCRIPTION LOCATION
Exhibit 10.1 Agreement, dated March 26, 2012, by and Provided Herewith
between the Company and YA Global
Investments, L.P.
Exhibit 10.2 Secured Convertible Debenture, No. Provided Herewith
NEOM-12-3, dated March 26, 2012, issued by
the Company to YA Global Investments, L.P.
Exhibit 10.3 Warrant, No. NEOM-0312, dated March 26, Provided Herewith
2012, issued by the Company to YA Global
Investments, L.P.
Exhibit 10.4 Security Agreement, dated July 29, 2008, by Incorporated by
and among the Company, each of the Company's reference to Exhibit
subsidiaries made a party thereto and YA 10.3 in the Company's
Global Investments, L.P. Current Report on Form
8-K as filed with the
SEC on August 4, 2008
Exhibit 10.5 Patent Security Agreement, dated July 29, Incorporated by
2008, by and among the Company, each of the reference to Exhibit
Company's subsidiaries made a party thereto 10.4 in the Company's
and YA Global Investments, L.P. Current Report on Form
8-K as filed with the
SEC on August 4, 2008
Exhibit 10.6 Seventeenth Ratification Agreement, dated Provided Herewith
March 26, 2012, by and among the Company,
each of the Company's subsidiaries made a
party thereto, and YA Global Investments,
L.P.
Exhibit 10.7 Irrevocable Transfer Agent Instructions, Provided Herewith
dated March 26, 2012, by and among the
Company, the Buyer, David Gonzalez, Esq. and
WorldWide Stock Transfer, LLC
My MDFI Pitch: "This will be the best revenue year since 2006. The fourth quarter should be great as open enrollments have started for next year. Year end 2009 revenue $14,264
Year end 2010 revenue $133,869
First 3 quarters revenue $403,644.
Looks like GROWTH to me...."